Search

Your search keyword '"Farkas, Klaudia"' showing total 661 results

Search Constraints

Start Over You searched for: Author "Farkas, Klaudia" Remove constraint Author: "Farkas, Klaudia"
661 results on '"Farkas, Klaudia"'

Search Results

1. Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years

3. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

5. Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies

6. Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases.

7. Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab – A prospective, multicenter cohort from Hungary

8. Long-term outcomes after endoscopic removal of malignant colorectal polyps: Results from a 10-year cohort

10. Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn's Disease.

11. Terápiás kihívások nehezen kezelhető, penetráló Crohn-betegségben – multidiszciplináris megoldás.

12. Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years

13. A fekélyes vastagbélgyulladás gyógyszeres és sebészeti kezelése

14. A Crohn-betegég terápiás stratégiája

15. Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

20. Plasminogen activator inhibitor 1 is a novel faecal biomarker for monitoring disease activity and therapeutic response in inflammatory bowel diseases

21. Risk Factors and Interpretation of Inconclusive Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology in the Diagnosis of Solid Pancreatic Lesions

23. Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system.

24. Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.

25. Szűrő kolonoszkópos vizsgálatok hatékonyságának és biztonságosságának értékelése a Szegedi Tudományegyetemen és a Bács-Kiskun Vármegyei Oktatókórházban 2019 és 2022 között

26. Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab.

28. Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey

29. Conception and reality: Outcome of SARS-CoV-2 infection and vaccination among Hungarian IBD patients on biologic treatments

31. Burnout among European IBD specialists: a survey supported by ECCO.

32. EFICACIA Y SEGURIDAD DEL TRATAMIENTO DE RESCATE EN LA COLITIS ULCEROSA CORTICORREFRACTARIA GRAVE REFRACTARIA A INFLIXIMAB O CICLOSPORINA (ESTUDIO REASUC)

33. Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone

36. Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination

37. Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls

38. sj-docx-1-tag-10.1177_17562848231174298 – Supplemental material for Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls

39. sj-docx-1-tag-10.1177_17562848231183529 – Supplemental material for Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination

40. Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls

42. Tápcsatornai endoszkópos eljárásokkal összefüggő infekciós kockázat a SARS-CoV-2-járvány idején.

46. Az alsó tápcsatornai endoszkópos ultrahangvizsgálat.

49. Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies

50. Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

Catalog

Books, media, physical & digital resources